Elimination of transmission of onchocerciasis (river blindness) with long-term ivermectin mass drug administration with or without vector control in sub-Saharan Africa: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Elimination of transmission of onchocerciasis (river blindness) with long-term ivermectin mass drug administration with or without vector control in sub-Saharan Africa: a systematic review and meta-analysis

Published:2024-05 Issue:5 Volume:12 Page:e771-e782
ISSN:2214-109X
Container-title:The Lancet Global Health
language:en
Short-container-title:The Lancet Global Health

Author:

Mutono Nyamai,Basáñez Maria-Gloria,James Ananthu,Stolk Wilma A,Makori Anita,Kimani Teresia Njoki,Hollingsworth T Déirdre,Vasconcelos Andreia,Dixon Matthew A,de Vlas Sake J,Thumbi S M

Funder

Bill & Melinda Gates Foundation

Publisher

Elsevier BV

Reference59 articles.

1. Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin;Komlan;PLoS Negl Trop Dis,2018

2. Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in south-west Cameroon;Forrer;BMJ Glob Health,2021

3. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019;Vos;Lancet,2020

4. The temporal relationship between onchocerciasis and epilepsy: a population-based cohort study;Chesnais;Lancet Infect Dis,2018

5. Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis;Basáñez;Lancet Infect Dis,2008

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Usability, acceptability and cost of the SD BIOLINE Ov16 rapid diagnostic test for onchocerciasis surveillance in endemic communities in the middle belt of Ghana;2024-05-09

2. Onchocerciasis elimination in sub-Saharan Africa requires alternative strategies;The Lancet Global Health;2024-05